MarketInOut Stock Screener Log In | Sign Up
 

Edwards Lifesciences Corp

NYSE • Healthcare • Medical Devices • Quote as of 05/15/2026
Edwards Lifesciences Corp stock price and volume chart

Company Profile

IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization46,836 mln
Float574 mln
Earnings Date07/23/2026

EPS

1.85
Stretched

P / E

43.99
High premium

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.3
Borderline

1-Year Forecast

97.15
Attractive

Relative Strength

25 / 100
Underperforming

Business Description

Founded in 1958 and based in Irvine, California, Edwards Lifesciences develops medical devices aimed at treating serious heart conditions across the United States and global markets. The company is best known for its range of heart valve products, including minimally invasive options that can replace or repair damaged valves without open-heart surgery, sold under brands such as SAPIEN, PASCAL, EVOQUE, and INSPIRIS. Its products reach patients through both a dedicated in-house sales team and independent distribution partners worldwide.

Key Fundamentals

EPS1.85
P/E43.99
ROE10.45
RPS10.36
ROIC16.23
ROA8.04
Interest Cover80.21
EBITDA, mln1,450
EV / EBITDA31.03
EV / EBIT34.79
Revenue, mln6,068
EV / Revenue7.42

Financial Strength

Altman Z-Score10.85
Piotroski F-Score 5 / 9
Beneish M-Score-2.3
Price to Intrinsic Value2.57
Price to Lynch Fair Value4.62
Price to Graham Number2.99
1-Year Target Price97.15
Shiller PE Ratio33.07
Short Ratio1.92
Short % of Float2.08

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.78% 88 / 100   
1 Month 2.95% 73 / 100   
2 Months 3.39% 66 / 100   
6 Months -4.91% 21 / 100   
1 Year 6.03% 33 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us